Skip Navigation



BJA Advance Access published online on May 8, 2009

British Journal of Anaesthesia, doi:10.1093/bja/aep099
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/6/812    most recent
aep099v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yoo, K. Y.
Right arrow Articles by Lee, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoo, K. Y.
Right arrow Articles by Lee, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia

K. Y. Yoo1,*, C. W. Jeong1, B. Y. Park1, S. J. Kim1, S. T. Jeong1, M. H. Shin2 and J. Lee3

1 Department of Anaesthesiology
2 Department of Preventive Medicine
3 Department of Physiology, Chonnam, National University Medical School, 8 Hak-dong, Gwangju 501-190, South Korea

* Corresponding author. E-mail: kyyoo{at}jnu.ac.kr

Background: We examined the effects of remifentanil on cardiovascular and bispectral index (BIS) responses to tracheal intubation and neonatal outcomes in pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia.

Methods: Forty-two women with severe pre-eclampsia were randomly assigned to receive either remifentanil 1 µg kg–1 (n=21) or saline (n=21) over 30 s before induction of anaesthesia using thiopentone 4 mg kg–1 and suxamethonium 1.5 mg kg–1. Mean arterial pressure (MAP), heart rate (HR) and BIS values as well as plasma catecholamine concentrations were measured. Neonatal effects were assessed using Apgar scores and umbilical cord blood gas analysis.

Results: Induction with thiopentone caused a reduction in MAP and BIS in both remifentanil and control groups. Following the tracheal intubation MAP and HR increased in both groups, the magnitude of which was lower in the remifentanil group. BIS values also increased, of which magnitude did not differ between the groups. Norepinephrine concentrations increased significantly following the intubation in the control, while remained unaltered in the remifentanil group. The neonatal Apgar scores at 1 min were significantly lower in the remifentanil group than in the control. However, Apgar scores at 5 min, and umbilical artery and vein blood gas values were similar between the groups.

Conclusions: These results suggest that a single bolus of 1 µg kg–1 remifentanil effectively attenuates haemodynamic but not BIS responses to tracheal intubation in pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. However, its use was associated with maternal hypotension and neonatal respiratory depression requiring resuscitation.

Keywords: anaesthetic techniques, induction; anaesthetic techniques, laryngoscopy; cardiovascular system, effects; complications, intubation tracheal; monitoring, bispectral index; opioids, remifentanil


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.